Vaginal rings estradiol

Vaginal rings Estradiol (Estring , Femring ) 1 ring every 3 months... 

Avoid systemic (parenteral, oral, TD) vaginal tablet, cream, intravaginal ring Estradiol 25 meg vaginal tablets (insert one PV daily x 14 days, then one PV twice weekly)... 

Estradiol 2 mg vaginal ring (1 ring PV every 3 months) Use local route to minimize systemic BA and side effects... 

New evidence indicates that lower doses of estrogens are effective in controlling postmenopausal symptoms and reducing bone loss (see Table 31-2). Even ultralow doses of 17 /J-estradiol delivered by vaginal ring improved serum lipid profiles and prevented bone loss in elderly women. 

Vaginal products Estradiol vaginal ring may not be suitable for women with narrow, short, or stenosed vaginas. Women with signs or symptoms of vaginal irritation should alert their physician. 

If a vaginal infection develops during use of the estradiol vaginal ring, remove the ring and reinsert only after the infection has been appropriately treated. 

Al-Azzawi F, Buckler HM. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms. Climacteric 2003 6 118-27. 

Bachmann G. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade. I Reprod Med 1998 43(ll) 991-8. 

Gabrielsson, J., et al. 1995. New kinetic data on estradiol in light of the vaginal ring concept. Matutitas S35-S39. 

Bachmann, G. 1995. The estradiol vaginal ring—A study of existing clinical data. Matutitas S21-S39. 

Ethinyl estradiol Etonogestrel NuvaRing (vaginal ring)... 

Timmer, C. J., and Mulders,T. M. (2000), Pharmacokinetics of etonogestrel and ethinyl-estradiol released from a combined contraceptive vaginal ring, Clin. Pharmacokinet., 39, 233-242. 

Nash, H. A., Brache, V., Alvarez-Sanchez, F., Jackanicz,T. M., and Harmon,T. M. (1997), Estradiol delivery by vaginal rings Potential for hormone replacement therapy, Maturitas, 26, 27-33. 

Eriksen, B. (1999), A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women, Am. J. Obstet. Gynecol., 180,1072-1079. 

When the efficacy of a vaginal ring, which delivers a continuous low dose of estradiol, was compared with a vaginal cream, both formulations were found to be equally effective and safe in the treatment of postmenopausal women with urogenital atrophy symptoms. ... 

Henriksson, L. Stjernquist, M. Boquist, L. Alander, U. Selinus, I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am. J. Obstet. Gyn. 1994, 171, 624—632. 

---